LAZARD ASSET MANAGEMENT LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1207017
NEW YORK, NY
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$169,948
-$116,402 QoQ
Shares Held
2,085
-54.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#385
of 497 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $400,660,289 across 59 Biotechnology names. ARWR ranks #49 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
131,996 | $122,461,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
93,287 | $46,338,451 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
90,348 | $25,746,469 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,910 | $23,014,861 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
350,397 | $20,049,716 | |
| 6 | EXEL |
Exelixis, Inc.
|
343,029 | $18,664,207 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
69,588 | $16,768,620 | |
| 8 | INCY |
Incyte Corp
|
136,684 | $15,494,498 |
All Filings in ARWR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $169,948 | 2,085 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $286,350 | 4,567 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $91,181 | 5,771 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $357 | 19 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $368 | 19 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $60,502 | 2,328 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $103,788 | 3,629 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $124,388 | 4,065 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $107,962 | 4,018 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $86,616 | 2,429 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $94,310 | 3,713 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $127,641 | 3,147 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $125,952 | 3,811 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $133,938 | 3,804 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $88,622 | 1,927 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $93,018 | 1,403 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,676,056 | 26,847 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $209,533 | 2,530 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,453 | 37 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,839 | 37 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||